VALENCE LABS
LIVE

Serial Number

98137246

Owner

Recursion Pharmaceuticals, Inc.

Attorney

David Johnson

Filing Date

Aug 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VALENCE LABS Trademark

Serial Number: 98137246

VALENCE LABS is a trademark filed by Recursion Pharmaceuticals, Inc. on August 17, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Recursion Pharmaceuticals, Inc.

41 South Rio Grande Street
Salt Lake City, UT 84101

Entity Type: 03

Trademark Details

Filing Date

August 17, 2023

Registration Date

Not Registered

Published for Opposition

November 11, 2025

Goods & Services

Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding

Downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jun 26, 2026 EX1G
SOU EXTENSION 1 FILED
Jun 26, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 26, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 21, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 13, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 2, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023 NWOS
NEW APPLICATION ENTERED
Aug 21, 2023 NWAP